Role of hepatic metabolism in the bioactivation and detoxication of amodiaquine

References

• Barrow A. The disposition and metabolism of amodiaquine in small mammals. Xenobiotica 1974; 4: 669–680
   Web of Science ®Google Scholar
• Boersma M. G., Gnubben N. H. P., Van Berkel W. J. H., Vervoort J., Rietjens I. M. C. M. Role of cytochromes P450 and flavin containing monooxygenase in the biotransformations of 4-fluoro-N-methyl aniline. Drug Metabolism and Disposition 1993; 21: 218–230
   PubMed Web of Science ®Google Scholar
• Bryce T. A., Maxwell J. R. Identification of the N-oxide group by mass spectrometry. Chemical Communications 1965; 206–207
   Web of Science ®Google Scholar
• Burckhalter J. B., Tendick F. H., Jones E. M., Jones P. A., Holcomb W. F., Rawlins A. L. Aminoalkylphenols as antimalarials. II. (heterocyclic-amino)α-amino-o-cresols. The synthesis of Camoquin. Journal of the American Chemical Society 1948; 70: 1363–1373
   PubMed Web of Science ®Google Scholar
• Christie G., Breckenridge A. M., Park B. K. Production of antibodies towards amodiaquine and amodiaquine quinoneimine in man and the rat. Biochemical Pharmacology 1989; 38: 1451–1458
   PubMed Web of Science ®Google Scholar
• Churchill F. C., Patchen L. C., Campbell C. C., Schwartz I. K., Nguyen-Dinh P., Dickinson C. M. Amodiaquine as a prodrug: importance of metabolite(s) in the antimalarial effect of amodiaquine in humans. Life Sciences 1984; 36: 53–62
   Google Scholar
• Clarke J. B., Maggs J. L., Kitteringham N. R., Park B. K. Immunogenicity of amodiaquine in the rat. International Archives of Allergy and Applied Immunology 1990; 91: 335–342
   PubMedGoogle Scholar
• Clarke J. B., Neftel K., Kitteringham N. R., Park B. K. Detection of antidrug IgG antibodies in patients with adverse drug reactions to amodiaquine. International Archives of Allergy and Immunology 1991; 95: 369–375
   Google Scholar
• Ebner T., Burchell B. Substrate specificities of two stably expressed human liver UDP-glucuronosyltransferases of the UGTI gene family. Drug Metabolism and Disposition 1993; 21: 50–55
   PubMed Web of Science ®Google Scholar
• Gorrod J. W., Gooderham N. J. The metabolism of N-benzyl-4-substituted anilines: factors influencing in vitro C- and N-oxidation. Xenobiotica 1977; 7: 165–177
   PubMedGoogle Scholar
• Halpert J. R., Guengerich F. P., Bend J. R., Correia M. A. Selective inhibitors of cytochromes P450. Toxicology and Applied Pharmacology 1994; 125: 163–175
   PubMed Web of Science ®Google Scholar
• Harrison A. C., Jewell H., Maggs J. L., Park B. K. Characterisation of a glucuronide of hydroxychloroquine. British Journal of Clinical Pharmacology 1993; 36: 145P
   Google Scholar
• Harrison A. C., Kitteringham N. R., Clarke J. B., Park B. K. The mechanism of bioactivation of amodiaquine in the rat. Biochemical Pharmacology 1992; 43: 1421–1430
   PubMed Web of Science ®Google Scholar
• Hatton C. S. R., Peto T. E. A., Bunch C. Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria. Lancet 1986; i: 411–413
   Google Scholar
• Hines R. N., Cashman J. R., Philpot R. M., Williams D. E., Ziegler D. M. The mammalian flavin-containing monooxygenases: molecular characterization and regulation of expression. Toxicology and Applied Pharmacology 1994; 125: 1–6
   PubMed Web of Science ®Google Scholar
• Jackson C-J. C., Hubbard J. W., Midha K. K. Biosynthesis and characterization of glucuronide metabolites of fluphenazine: 7-hydroxyfluphenazine glucuronide and fluphenazine glucuronide. Xenobiotica 1991; 21: 383–393
   PubMed Web of Science ®Google Scholar
• Laurent F., Saivin S., Chrettien P., Magnaval J. F., Peyron F., Squalli A., Tufenkji A. E., Coulais Y., Baba H., Campistron G., Regis H., Ambroise P., Bryskier A., Houin G. Pharmacokinetic and pharmacodynamic study of amodiaquine and its two major metabolites after a single oral dose in human volunteers. Arzneimittel Forschung Drug Research 1993; 43: 621–616
   Google Scholar
• Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Maggs J. L., Tingle M. D., Kitteringham N. R., Park B. K. Drug-protein conjugates. XIV. Mechanisms of formation of protein arylating intermediates from amodiaquine, a myelotoxin and hepatotoxin in man. Biochemical Pharmacology 1988; 37: 303–311
   PubMed Web of Science ®Google Scholar
• McChesney E. W. Animal toxicity and pharmacokinetics of hydroxychloroquine sulphate. American Journal of Medicine 1983; 75: 11–18
   PubMed Web of Science ®Google Scholar
• Meredith G. C., Maldonado A. L., Speeg K. V. The effect of ketoconazole on hepatic drug metabolism in the rat in vivo and in vitro. Drug Metabolism and Disposition 1985; 13: 156–162
   PubMed Web of Science ®Google Scholar
• Neftel K. A., Woodtly W., Schmid M., Frick P. G., Fehr J. Amodiaquine-induced agranulocytosis and liver damage. British Medical Journal 1986; 292: 721–723
   PubMed Web of Science ®Google Scholar
• O'Neill P. M., Harrison A. C., Storr R. C., Hawley S. R., Ward S. A., Park B. K. The effect of fluorine substitution on the metabolism and antimalarial activity of amodiaquine. Journal of Medicinal Chemistry 1994; 37: 1362–1370
   PubMedGoogle Scholar
• Potter D. W., Hinson J. A. Reactions of N-acetyl-p-benzoquinone imine with reduced glutathione, acetaminophen, and NADPH. Molecular Pharmacology 1986; 30: 33–41
   PubMed Web of Science ®Google Scholar
• Purba H. S., Maggs J. L., Orme M. L'E., Back D. J., Park B. K. The metabolism of 17-alpha-ethinylestradiol by human liver microsomes: formation of catechol and chemically reactive metabolites. British Journal of Clinical Pharmacology 1987; 23: 447–453
   PubMed Web of Science ®Google Scholar
• Pussard E., Faurisson F., Scherrman J. M., Le Bras J., Blayo M. C. Disposition of monodesethylamodiaquine after a single oral dose of amodiaquine and three regimens for prophylaxis against Plasmodium falciparum malaria. European Journal of Pharmacology 1987; 33: 409–414
   Google Scholar
• Raymond J. M., Dumas F., Baldit C., Couzigou P., Beraud C., Amourgiti M. Fatal acute hepatitis due to amodiaquine. Journal of Clinical Gastroenterology 1989; 11: 602–603
   PubMedGoogle Scholar
• Rietjens I. M. C. M., Vervoort J. Bioactivation of 4-fluorinated anilines to benzoquinoneimines as primary reaction products. Chemical Biological Interactions 1991; 77: 263–281
   PubMed Web of Science ®Google Scholar
• Rouveix B., Coulombel L., Aymard J. P., Chau F., Abel L. Amodiaquine-induced immune agranulocytosis. British Journal of Haematology 1989; 71: 7–11
   PubMed Web of Science ®Google Scholar
• Ruijten H M., De Bree H., Borst A J. M., De Lange N., Scherpenisse P. M., Vincent W. R., Post L. C. Fluvoxamine: metabolic fate in animals. Drug Metabolism and Disposition 1984; 12: 82–92
   PubMedGoogle Scholar
• Straub K. M., Rudewicz P., Garvie C. ‘Metabolic mapping’ of drugs: rapid screening techniques for xenobiotic metabolites with ms/ms techniques. Xenobiotica 1987; 17: 413–422
   PubMed Web of Science ®Google Scholar
• Tephly T., Green M., Puig J., Irshaid Y. Endogenous substrates for UDP-glucuronosyl-transferases. Xenobiotica 1988; 18: 1201–1210
   PubMed Web of Science ®Google Scholar
• Vage C., Svensson C. K. Evidence that the biotransformation of dapsone and monoacetyldapsone to their respective hydroxylamine metabolites in rat liver microsomes is mediated by cytochrome P450 2C6/2C11 and 3A1. Drug Metabolism and Disposition 1994; 22: 572–577
   PubMed Web of Science ®Google Scholar
• Wallis C. M., Gray A., Vose C. W., Robinson Y., Lopez N., Brownsill R. D., Steiner J. A. Disposition of bemitradine, a renal vasodilator and diuretic, in man. Xenobiotica 1988; 18: 1413–1423
   PubMedGoogle Scholar
• Watkins W., Sixsmith D., Spencer H., Bonga D., Kariuki D., Kiplingor T. Effectiveness of amodiaquine as a treatment for chloroquine resistant Plasmodium falciparum in Kenya. Lancet 1984; i: 357–359
   Google Scholar
• Winstanley P. A., Edwards G., Curtis C. G., L'E Orme M., Powell G. M., Breckenridge A. M. Tissue distribution and excretion of amodiaquine in the rat. Journal of Pharmacy and Pharmacology 1988; 40: 343–349
   PubMed Web of Science ®Google Scholar
• Zak S. B., Tallan H. H., Quinn G. P., Fratta I, Greengard P. The determination and physiological distribution of dipyridamole and its glucuronides in biological material. Journal of Pharmacology and Experimental Therapeutics 1963; 141: 392–398
   PubMedGoogle Scholar